Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. III
5. TTEC
6. DAL
7. AWK
8. SPCX
9. ANDE
10. BV

Go back to Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
(NASDAQ: PPBT) Delayed: 1.70 -0.06 (3.41%)
Previous Close $1.76    52 Week High $ 
Open $1.75    52 Week Low $ 
Day High $1.79    P/E N/A 
Day Low $1.66    EPS $ 
Volume 35,477       

(NASDAQ: PPBT) Delayed: 1.70 -0.06 (3.41%)
Previous Close $1.76    52 Week High $ 
Open $1.75    52 Week Low $ 
Day High $1.79    P/E N/A 
Day Low $1.66    EPS $ 
Volume 35,477